The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jenkins, C. E.
Right arrow Articles by Lin, T.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jenkins, C. E.
Right arrow Articles by Lin, T.-J.
The Journal of Immunology, 2006, 177: 8000-8007.
Copyright © 2006 by The American Association of Immunologists, Inc.

Pseudomonas aeruginosa-Induced Human Mast Cell Apoptosis Is Associated with Up-Regulation of Endogenous Bcl-xS and Down-Regulation of Bcl-xL1

Christopher E. Jenkins, Ania Swiatoniowski, Melanie R. Power and Tong-Jun Lin2

Department of Microbiology and Immunology and Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
Mast cells play a critical role in the host defense against bacterial infection. Recently, apoptosis has been demonstrated to be essential in the regulation of host response to Pseudomonas aeruginosa. In this study we show that human mast cell line HMC-1 and human cord blood-derived mast cells undergo apoptosis as determined by the ssDNA formation after infection with P. aeruginosa. P. aeruginosa induced activation of caspase-3 in mast cells as evidenced by the cleavage of D4-GDI, an endogenous caspase-3 substrate and the generation of an active form of caspase-3. Interestingly, P. aeruginosa treatment induced up-regulation of Bcl-xS and down-regulation of Bcl-xL. Bcl-xS, and Bcl-xL are alternative variants produced from the same Bcl-x pre-mRNA. The former is proapoptotic and the latter is antiapoptotic likely through regulating mitochondrial membrane integrity. Treatment of mast cells with P. aeruginosa induced release of cytochrome c from mitochondria and loss of mitochondrial membrane potentials. Moreover, P. aeruginosa treatment reduced levels of Fas-associated death domain protein-like IL-1beta-converting enzyme-inhibitory proteins (FLIPs) that are endogenous apoptosis inhibitors through counteraction with caspase-8. Thus, human mast cells undergo apoptosis after encountering P. aeruginosa through a mechanism that likely involves both the Bcl family protein mitochondrial-dependent and the FLIP-associated caspase-8 pathways.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
Mast cells are abundant in the tissues adjacent to external surfaces such as lung, intestine, or skin. Mast cells have been repeatedly demonstrated to be critical in the host defense against bacterial infection (1, 2, 3). Direct evidence of a role for mast cells in host defense against bacterial infection comes from the study using mast cell-deficient W/Wv mice. In a model of cecal ligation and puncture-induced peritonitis and a model of Klebsiella pneumonia-induced peritonitis or lung infection, animals with a normal number of mast cells survived bacterial challenge, whereas W/Wv mice did not (1, 2). To date, a role for mast cells in the host defense against bacterial infection has been attributed to their released products such as IL-1 and TNF, which in turn recruit other immune cells for the clearance of the pathogen (1, 2, 4). However, little is known about the fate of these mast cells after encountering live bacterial pathogen.

Apoptosis plays a central role in the balance between host defense and the invading pathogen (5). Depending upon the nature of the bacterial pathogen and the population of host cells, apoptosis of the host cells may be detrimental or beneficial to the survival of the host organism. Pseudomonas aeruginosa pneumonia-induced bronchial cell apoptosis is essential for survival, likely through shedding of infected apoptotic bronchial cells (6). In contrast, lymphocyte apoptosis during infection is detrimental, and prevention of lymphocyte apoptosis improves the chances of survival (7). Thus, it is important to differentiate and characterize the apoptotic response in a specific cell population during P. aeruginosa infection. Some cell types such as airway epithelium or endothelial cells are highly resistant to apoptosis in P. aeruginosa pneumonia (5, 8), whereas other cell types such as lymphocytes are highly susceptible to apoptosis during P. aeruginosa infection (5). Mast cells in the lung directly protrude into the airway space that allows the direct interaction of mast cells with bacterial pathogens (9). Although several purified bacterial products such as toxin A from P. aeruginosa (10) or Clostridium difficile (11), or LPS (12) modulate mast cell apoptosis, it is not known whether live P. aeruginosa infection induces mast cell apoptosis.

Caspase-3 activation plays a central role in the execution of apoptosis. Depending upon the specific cell type, two pathways have been reported to be involved in the activation of caspase-3. The death receptor-caspase-8 pathway is essential for apoptosis in type I cells such as lymphocytes (13). Fas-associated death domain-like IL-1-converting enzyme-inhibitory proteins (FLIPs)3 are endogenous inhibitors that counteract caspase-8 pathway activation (14). Although a mitochondria-caspase-9 pathway is required for robust apoptosis in the type II cells such as hepatocytes (15, 16), the balance between the antiapoptotic Bcl family members such as Bcl-xL and Bcl-2 and proapoptotic Bcl family members such as Bcl-xS plays an essential role in maintaining the mitochondrial membrane integrity and regulates mitochondrial pathway-dependent apoptosis (17). Mast cells appear to have mechanisms involving both the FLIPs-associated receptor-caspase-8 pathway (18) and the Bcl family protein-mitochondrial pathway to regulate apoptosis (12).

Alternative splicing of the Bcl-x pre-mRNA gives rise to two transcripts, coding for either a long-form (Bcl-xL) or a short-form (Bcl-xS) of the protein (19). Bcl-xL inhibits apoptosis through heterodimerization with proapoptotic proteins (20). In contrast, Bcl-xS is proapoptotic through antagonizing survival proteins such as Bcl-xL or Bcl-2 (20). Due to the antagonistic functions of these two splice variants, a shift of the Bcl-xL to Bcl-xS ratio regulates the apoptotic process. The shift in splicing from Bcl-xL to Bcl-xS has been achieved by artificial antisense oligonucleotides and rendered cells to apoptosis (21, 22). Although the importance of the balance between Bcl-xL and Bcl-xS in control of apoptosis has been well recognized, it is not known whether this mechanism of alternative splicing is involved in pathogen-host interaction.

In this study, we demonstrated that human mast cells underwent apoptosis as determined by ssDNA formation in response to live, but not killed P. aeruginosa infection. Similarly, live but not killed P. aeruginosa induced caspase-3 activation in human mast cells. Interestingly, P. aeruginosa infection induced up-regulation of Bcl-xS and down-regulation of Bcl-xL, a shift from Bcl-xL to Bcl-xS expression in mast cells. In addition, P. aeruginosa reduced FLIPs levels in mast cells. To our knowledge, this demonstration is the first to show that a shift from Bcl-xL to Bcl-xS is associated with bacteria-induced apoptosis in mammalian cells. Our results suggest that P. aeruginosa-induced human mast cell apoptosis likely involves Bcl family protein mitochondrial-dependent and FLIP-associated death receptor pathways.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 Disclosures
 References
 
Reagents

Mouse anti-ssDNA mAb (IgM), biotinylated mouse anti-Bcl-xL/Bcl-xS, rabbit anti-FLIPshort, and rabbit anti-FLIPlong Abs were purchased from Chemicon International. Mouse anti-rat neutrophil mAb (RP-3, IgM) isotype control was a gift from F. Sendo (Yamagata University, Yamagata, Japan). Rabbit anti-active caspase-3 IgG and rabbit anti-human cytochrome c were purchased from Cell Signaling Technology. Rabbit FITC-conjugated anti-active caspase-3 IgG was purchased from BD Biosciences. Mouse anti-D4-GDI (specific for the 23-kDa form) mAb was purchased from Imgenex. Mouse anti-human Bcl-2 (IgG1) was purchased from Upstate Biotechnology. Goat anti-actin IgG, donkey anti-goat IgG HRP, donkey anti-rabbit IgG HRP, and donkey anti-mouse IgG HRP Ab conjugates were purchased form Santa Cruz Biotechnology. Goat PE-conjugated IgG to mouse IgM was purchased from Caltag Laboratories. 3,3'-Dihexyloxacarbocyanine iodide (DioC6) was from Molecular Probes. Purified P. aeruginosa exotoxin A was purchased from List Biological Laboratories. Camptothecin was obtained from Sigma-Aldrich. FBS, penicillin/streptomycin, IMDM, and RPMI 1640 medium were purchased from Invitrogen Life Technologies. All other chemicals and reagents were of analytical grade.

Mast cells and culture conditions

Human mast cells HMC-1 5C6 were maintained in IMDM in a 5% CO2-humidified atmosphere at 37°C. Culture medium was supplemented with 10% FBS and 50 U/ml each of penicillin and streptomycin.

Highly purified cord blood-derived mast cells (CBMC) (>95% purity) were obtained by long term culture of cord blood progenitor cells as previously described (23). The percentage of mast cells in the cultures was determined by toluidine blue staining (pH 1.0) of cytocentrifuged samples. Mature mast cells after more than 8 wk in culture were identified by their morphological features and the presence of metachromatic granules, at which time they were used for this study.

Murine primary cultured bone marrow-derived mast cells (BMMC) were harvested from the femurs and tibias of C57-black mice from Charles River Breeding Laboratories and maintained as previously described (24). Following 5 wk of culture, mast cell purity of >98% was achieved as assessed by toluidine blue staining. Mature mast cells were identified by their morphological features and granule prevalence.

Bacterial preparation and treatment with mast cells

P. aeruginosa strain 8821, a gift from Dr. A. Chakrabarty, University of Illinois (Chicago, IL), is a mucoid strain isolated from a cystic fibrosis patient (25). P. aeruginosa was cultured in Luria-Bertani broth and harvested when the culture reached an OD at 640 nm of 2 OD units (early stationary phase). Bacteria were washed in PBS and density adjusted to 1 OD unit before use. For killed P. aeruginosa experiments, bacteria were treated with gentamicin (100 µg/ml) for 2 h and exposed directly to UV light illumination for 20 min before experimental use. For live P. aeruginosa experiment, mast cells were treated with live P. aeruginosa for 3 h at various multiplicity of infection (MOI) values, and then a mixture of antibiotics was added to kill P. aeruginosa (200 µg/ml gentamicin, 1% penicillin/streptomycin (v/v) each 50 U/ml, 100 µg/ml ceftazidime, and 100 µg/ml piperacillin). Death of bacteria was confirmed by plating mast cell culture on Luria-Bertani agar plates.

Detection of ssDNA by flow cytometry

P. aeruginosa-treated or sham-treated mast cells were fixed, permeabilized, and stained with a mAb specific for segments of ssDNA as previously described (26). Briefly, mast cells were fixed for 1–3 days in methanol at –20°C and subsequently heated in formamide at 70°C for 10 min. Nonspecific binding was blocked with 1% nonfat dry milk (w/v) in PBS. Cells were stained with anti-ssDNA or IgM isotype control, followed by washing and incubation with a PE-conjugated anti-mouse IgM Ab. After washing, cells were analyzed with a FACSCalibur flow cytometer (BD Biosciences).

Preparation of total cell lysate

Treated cells (0.25 x 105–2.5 x 106) were homogenized in ice-cold radioimmune precipitation assay radioimmunoprecipitation assay buffer (50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 50 mM NaHPO4, 0.25% sodium deoxycholate (w/v), 0.1% Nonidet P-40 (v/v), 1 mM Na3VO4, and 1 mM NaF) containing freshly added protease and phosphatase inhibitors (2 mM PMSF, 1 µg/ml aprotinin, 1 µg/ml leupeptin, 1 µg/ml pepstatin A, 5 mM EDTA, 5 mM EGTA, and 2 mM iodoacetamide). Lysates were typically incubated on ice for at least 20 min before centrifugation at 15,000 x g to remove cellular debris. Protein was quantified using a protein quantification reagent according to the manufacturer (Bio-Rad).

Western blotting for active caspase-3, D4-GDI, Bcl-xL/Bcl-xS, and FLIPs

Sample lysates containing 75 µg of protein (for caspase-3), 15 µg (for D4-GDI), 5 µg (for FLIPshort), and 30 µg (for FLIPlong, Bcl-xL/Bcl-xS, Bcl-2, or cytochrome c) were boiled for 5 min and subjected to SDS-10% PAGE. Gels were transferred to polyvinylidene difluoride membrane, and nonspecific binding was blocked using 10% nonfat dry milk. Membranes were then incubated overnight at 4°C with Abs to active caspase-3, D4-GDI, FLIPshort, FLIPlong, Bcl-xL/Bcl-xS, Bcl-2, or cytochrome c and detected by ECL detection reagent (Amersham Biosciences). Membranes were subsequently stripped (62.5 mM Tris-HCl (pH 6.8), 20% SDS (w/v), 100 mM 2-ME) and reprobed for actin.

Detection of active caspase-3 by flow cytometry

Treated mast cells (0.5–1 x 106) were fixed in 4% paraformaldehyde and subsequently stored in 10% DMSO in PBS at –80°C until staining. Cells were thawed and permeabilized with 0.1% saponin in PBS for 1 h followed by incubation in 3% BSA/PBS for 1 h to block nonspecific binding. Cells were then stained with FITC-conjugated rabbit mAb to active caspase-3, washed, and analyzed by flow cytometry.

Detection of mitochondrial membrane potential using DioC6

Changes of mitochondrial membrane potential were measured using DioC6 as described elsewhere with minor modifications (27). Mast cells were suspended in 40 nM DioC6 in medium for 30 min at 37°C. Cells were then transferred to flow cytometry polystyrene tubes and kept on ice. Cells were then analyzed by flow cytometry for green fluorescence.

Statistical analysis

Data were analyzed by one way ANOVA followed by Tukey’s posttest, using Instat GraphPad software (version 3.0) to determine the statistical difference between individual treatments. Statistical significance was defined as p < 0.05.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 Disclosures
 References
 
P. aeruginosa induces mast cell apoptosis

To determine whether P. aeruginosa induces mast cell apoptosis, an Ab specific for ssDNA was used because the generation of ssDNA is a specific indicator of apoptosis (26). HMC-1 cells were treated with various concentrations of live or killed P. aeruginosa strain 8821. Treatment of HMC-1 cells with live P. aeruginosa induced ssDNA formation in a concentration-dependent manner (Fig. 1, a and b). Interestingly, no ssDNA formation was detectable when HMC-1 cells were treated with killed P. aeruginosa (Fig. 1, a and b).


Figure 1
View larger version (26K):
[in this window]
[in a new window]
  		FIGURE 1. Induction of human mast cell apoptosis by P. aeruginosa. a and b, HMC-1 cells were treated with increasing concentrations of P. aeruginosa strain 8821 for 24 h before flow cytometric analysis for ssDNA. For the live P. aeruginosa experiment, mast cells were treated with live P. aeruginosa for 3 h at various MOI = 25, 50, or 100, and then a mixture of antibiotics was added to kill P. aeruginosa (200 µg/ml gentamicin, 1% penicillin/streptomycin (v/v) each 50 U/ml, 100 µg/ml ceftazidime, and 100 µg/ml piperacillin). Live P. aeruginosa induced concentration-dependent generation of ssDNA in HMC-1 5C6 cells. Results are expressed as mean percentage of ssDNA positive cells ± SEM from five independent experiments. *, p < 0.01 compared with HMC-1 cells treated with medium alone. Cells without P. aeruginosa treatment served as controls (NT). Mast cells treated with killed P. aeruginosa (50 killed, MOI = 50; 100 killed, MOI = 100) did not undergo apoptosis. c and d, Human CBMC were treated with medium, live or killed P. aeruginosa 8821 (MOI = 100), for 24 h, then fixed and stained for ssDNA. Similar to HMC-1 cells, CBMC undergo apoptosis after P. aeruginosa treatment. Results are expressed as mean ± SEM. *, p < 0.01 compared with cells treated with medium alone (n = 3).

 
To determine whether P. aeruginosa induces apoptosis in primary cultured human mast cells, human CBMC were treated with live or killed P. aeruginosa (mast cell to bacteria ratio is 1:100) for 24 h. Live but not killed P. aeruginosa induced ssDNA formation in CBMC as determined by flow cytometry (Fig. 1, c and d).

P. aeruginosa induces caspase-3 activation in mast cells

Because caspase-3 plays a central role in the execution of apoptosis, several approaches were taken to examine the activation of caspase-3 in mast cells following P. aeruginosa infection. To directly examine caspase-3 activation in human mast cells, an Ab that specifically recognizes the activated form of caspase-3 was used. HMC-1 cells were treated with live or killed P. aeruginosa with various MOI for 24 h. Cell lysates were used to determine caspase-3 activation by Western blotting. Treatment of mast cells with live P. aeruginosa induced an increase of active caspase-3 (Fig. 2a). Similar to ssDNA formation and D4-GDI cleavage, killed P. aeruginosa has little effect on caspase-3 activation (Fig. 2a).


Figure 2
View larger version (24K):
[in this window]
[in a new window]
  		FIGURE 2. P. aeruginosa induces activation of caspase-3 in mast cells. a, HMC-1 cells were treated with medium (NT) or increasing concentrations of live or killed P. aeruginosa (MOI = 25, 50 or 100) for 24 h, then lysed in radioimmunoprecipitation assay buffer. When live P. aeruginosa bacteria were used, antibiotics (see Fig. 1) were added at the 3 h and throughout the rest of the incubation period. Sample lysates were subjected to SDS-PAGE and analyzed by Western blotting with mAbs specific for active caspase-3 or actin. b and c, HMC-1 cells were treated with medium or P. aeruginosa for 24 h (MOI = 25, 50 or 100), then fixed and permeabilized for staining with FITC-conjugated anti-active caspase-3 Ab for flow cytometric analysis. Representative histograms show that live P. aeruginosa-treated HMC-1 5C6, but not medium treated (NT) or killed P. aeruginosa (killed 50, MOI = 50; killed 100, MOI = 100) treated cells were stained positive for active caspase-3 (b). Results are expressed as mean percentage of positive staining cells ± SEM of five independent experiments. *, p < 0.05 in c. d and e, Similar to HMC-1 cells, human CBMC after treatment with live, but not killed P. aeruginosa 8821 (MOI = 100) for 24 h were stained positive for active caspase-3. Results are expressed as mean ± SEM. *, p < 0.05 (n = 3).

 
To further determine the percentage of mast cell population positive for activated caspase-3, flow cytometry analysis was conducted using intracellular staining with a FITC-labeled mAb specific for the activated caspase-3. The population of mast cells positive for activated caspase-3 after P. aeruginosa treatment is dependent on the MOI (Fig. 2, b and c). Approximately 56% of HMC-1 cells were stained positive for activated caspase-3 when mast cells were infected with P. aeruginosa at the MOI of 1:100. Consistent with previous results, killed P. aeruginosa had little effect on caspase-3 activation (Fig. 2, b and c).

To confirm P. aeruginosa-induced caspase-3 activation in primary cultured human mast cells, CBMC were treated with live P. aeruginosa at the MOI of 1:100 for 24 h. CBMC were permeabilized and stained with anti-active caspase-3. Similar to HMC-1 cells, CBMC were stained positive for active caspase-3 after treatment with live, but not killed P. aeruginosa (Fig. 2, d and e).

P. aeruginosa induces D4-GDI cleavage in mast cells

We further confirmed P. aeruginosa-induced caspase-3 activation in mast cells by measuring D4-GDI cleavage. D4-GDI is one of the endogenous substrate for caspase-3 (28). Accordingly, cleavage of D4-GDI has been used as an indicator of caspase-3 activity (28). HMC-1 cells were treated with various concentrations of live or killed P. aeruginosa (strain 8821) for 24 h, and D4-GDI cleavage was determined by Western blotting. Treatment of P. aeruginosa induced significant D4-GDI cleavage leading to the generation of a 23-kDa product, which is specific to caspase-3 activity (Fig. 3). It is noteworthy that only live P. aeruginosa, but not killed P. aeruginosa, induced enhanced D4-GDI cleavage in mast cells, a pattern consistent with that of ssDNA formation.


Figure 3
View larger version (24K):
[in this window]
[in a new window]
  		FIGURE 3. P. aeruginosa-induced D4-GDI cleavage. HMC-1 cells were treated with live P. aeruginosa (strain 8821, MOI = 25, 50, or 100) for 3 h. Subsequently, antibiotics were added to kill the bacteria and further incubated for 21 h (total 24 h incubation). Cells without P. aeruginosa treatment served as controls (NT). Cell lysates were subjected to SDS-PAGE and Western blotting for the analysis of a 23-kDa cleavage fragment (specifically generated by active caspase-3) of the endogenous caspase-3 substrate D4-GDI. Blots that were probed for actin served as loading control.

 
P. aeruginosa increases Bcl-xS and decreases Bcl-xL levels in mast cells and decreases mitochondrial membrane potential

Mitochondria play an essential role in the initiation of the apoptotic process by release of proapoptotic substances into the cytosol to activate caspase-3. The balance between the antiapoptotic Bcl family members such as Bcl-xL and Bcl-2 and the proapoptotic Bcl family members such as Bcl-xS controls apoptosis through several mechanisms including maintaining the integrity of the mitochondria membrane by preventing the release of proapoptotic substances from the mitochondria (29). To examine whether P. aeruginosa regulates the levels of Bcl family members in mast cells, HMC-1 cells were treated with live P. aeruginosa with various MOI for 24 h. Cell lysates were used to examine the levels of Bcl-xS, Bcl-xL, and Bcl-2. Treatment of mast cells with P. aeruginosa induced decrease of the antiapoptotic Bcl family member Bcl-xL and increased the proapoptotic member Bcl-xS (Fig. 4). Interestingly, the level of Bcl-2 was unaffected by P. aeruginosa treatment (Fig. 4). Because Bcl-xL and Bcl-xS are splice variants, we determined the ratio of Bcl-xS to Bcl-xL. Treatment of mast cells with P. aeruginosa induced a consistent increase in the Bcl-xS to Bcl-xL ratio.


Figure 4
View larger version (33K):
[in this window]
[in a new window]
  		FIGURE 4. P. aeruginosa up-regulates Bcl-xS and down-regulates Bcl-xL in human mast cells. HMC-1 cells were treated with live P. aeruginosa (strain 8821, MOI = 25, 50, or 100) for 24 h (Antibiotics were added at 3 h and throughout the rest of the incubation period as in Fig. 1). Cells without P. aeruginosa treatment served as controls (NT). Cell lysates were subjected to SDS-PAGE and Western blotting with an Ab that recognizes both Bcl-xS and Bcl-xL. Blots were subsequently stripped and reprobed for Bcl-2 or actin (a). Densitometry analysis of Bcl-xL (b) or Bcl-xS (c) was performed based on three separate experiments. The increase of Bcl-xS to Bcl-xL ratio induced by P. aeruginosa treatment was shown (d).

 
To examine whether Bcl-xS expression is a specific effect induced by P. aeruginosa treatment, we examined the effect of two apoptosis-inducing agents (camptothecin and exotoxin A) on Bcl-xS expression in HMC-1 cells. Camptothecin is an anticancer chemical that induces cell apoptosis by inhibiting topoisomerase I (30). Treatment of HMC-1 with camptothecin (1 µM) induced D4-GDI cleavage, active caspase-3 production, and ssDNA formation (Fig. 5a) and reduced FLIPshort level (see Fig. 7a below). However, camptothecin at all concentrations tested (0.1, 1, and 5 µM) did not induce Bcl-xS expression, although at higher concentrations (1 and 5 µM) it reduced Bcl-xL level (Fig. 5b). This result is in contrast to live P. aeruginosa infection, which consistently induces Bcl-xS expression. Killed P. aeruginosa appears to have no effect on Bcl-xS expression (Fig. 5c).


Figure 5
View larger version (45K):
[in this window]
[in a new window]
  		FIGURE 5. P. aeruginosa, but not exotoxin A or camptothecin induce Bcl-xS expression in human mast cells or mouse BMMC. HMC-1 cells were treated for 24 h with camptothecin (Camp) 1 µM (a), 0.1, 1, and 5 µM (b), exotoxin A (ETA) 300 ng/ml, live P. aeruginosa (Psa live, MOI = 100), killed P. aeruginosa (Psa killed, MOI = 100), or without treatment (NT) (c). Cell pellets were used for the examination of D4-GDI, active caspase-3 and Bcl-xL to Bcl-xS levels by Western blotting and ssDNA formation by flow cytometry. d, Human umbilical CBMC were treated with camptothecin (1 µM), live or killed P. aeruginosa (Psa, MOI = 100) for 24 h. Cell pellets were used to examine Bcl-xL to Bcl-xS expression by Western blotting. e and f, Mouse BMMC were treated with camptothecin (Camp, 1 µM), live or killed P. aeruginosa (MOI = 100) for 24 h. Cell lysates were examined by Western blotting with Abs to active caspase-3, D4-GDI, Bcl-xL/Bcl-xS, or actin. Cells without treatment (NT) were used as controls.

 

Figure 7
View larger version (52K):
[in this window]
[in a new window]
  		FIGURE 7. P. aeruginosa down-regulates FLIPshort and FLIPlong in mast cells. HMC-1 cells were treated with camptothecin (Camp, 1 µM), exotoxin A (ETA, 300 ng/ml), killed P. aeruginosa (Psa killed, MOI = 100), or live P. aeruginosa strain 8821 (Psa live, MOI = 100) for 24 h (Antibiotics as described in Fig. 1 were added at 3 h and throughout the rest of the incubation period). Cell lysates were examined by Western blotting with Abs to FLIPshort (a), FLIPlong (b), or actin. Cells without P. aeruginosa treatment (NT) were used as controls.

 
Effects of P. aeruginosa exotoxin A on Bcl-xS formation were examined because we showed previously that exotoxin A induced HMC-1 cell apoptosis (10). HMC-1 cells were treated with exotoxin A (300 ng/ml) for 24 h. Interestingly, no effect of exotoxin A on Bcl-xS was observed (Fig. 5c).

To examine whether P. aeruginosa induces Bcl-xS formation in primary cultured human CBMC, mature CBMC were treated with live or killed P. aeruginosa for 24 h. Cell lysates were examined for Bcl-xS. As seen in HMC-1, Bcl-xS expression was induced by treatment with live but not killed P. aeruginosa (Fig. 5d). Camptothecin was used as a control and showed no effect on Bcl-xS expression.

To examine whether primary cultured mouse BMMC respond to P. aeruginosa, mature mouse BMMC were treated with live P. aeruginosa, killed P. aeruginosa, or camptothecin. Live P. aeruginosa induced increase of Bcl-xS, caspase-3 activation, and D4-GDI cleavage in mouse BMMC (Fig. 5, e and f). In contrast, killed P. aeruginosa had minor or no effects on Bcl-xS, active caspase-3, or D4-GDI levels, a pattern similar to that seen in HMC-1 cells. Similarly, although camptothecin induced caspase-3 activation and D4-GDI cleavage, it did not induce Bcl-xS formation (Fig. 5, e and f). Thus, mouse mast cells and human mast cells respond to P. aeruginosa and undergo apoptosis likely through similar mechanisms.

To determine whether P. aeruginosa treatment affects mast cell mitochondrial membrane permeability, DioC6 was used. HMC-1 cells were treated with live P. aeruginosa with various MOI for 24 h or treated with killed P. aeruginosa (MOI = 100) for 24 h. HMC-1 cells were also treated with camptothecin (1 µM) for 24 h as a control. After treatment, cells were stained with DioC6. Treatment with camptothecin or live, but not killed P. aeruginosa induced loss of mast cell mitochondrial membrane potential (Fig. 6, a and b), suggesting an increase of mitochondrial membrane permeability.


Figure 6
View larger version (34K):
[in this window]
[in a new window]
  		FIGURE 6. P. aeruginosa treatment induces loss of mitochondrial potential and release of cytochrome c from mitochondria to cytosol. a and b, HMC-1 cells were treated with various concentrations of live P. aeruginosa for 3 h (MOI = 25, 50, or 100). Then antibiotics (see Fig. 1) were added to kill bacteria and were present throughout the rest of 21 h incubation time (total 24 h incubation). Cells treated with killed P. aeruginosa (MOI = 100) or camptothecin (1 µM) served as controls. Cells were then used to stain with DioC6 and analyzed by flow cytometry. Representative flow cytometry histogram showed that P. aeruginosa treatment induces loss of mitochondrial potential in mast cells (a). Results are expressed as mean percentage of positive staining cells ± SEM of three independent experiments. *, p < 0.01 compared with no treatment group (b). c, HMC-1 cells were treated with live P. aeruginosa (Psa Live), killed P. aeruginosa (Psa Killed) (MOI = 100), or camptothecin (Camp, 1 µM) for 24 h. Cells were then subjected to mitochondria/cytosol fractionation to obtain mitochondria-free cytosol fraction. Cytosol proteins were probed for cytochrome c, D4-GDI, or actin by Western blotting. Cells without P. aeruginosa treatment (NT) were used as a control.

 
To further determine a role of mitochondrial pathway in P. aeruginosa-induced mast cell apoptosis, we examined whether P. aeruginosa treatment induces cytochrome c release into cytosol compartment. HMC-1 cells were treated with camptothecin (1 µM), live or killed P. aeruginosa (MOI = 100) for 24 h. Cells were then subjected to mitochondria-cytosol separation using a mitochondria-cytosol fractionation kit (BioVision). The release of cytochrome c in the cytosol fraction was examined by Western blotting. Treatment of mast cells with live P. aeruginosa induced release of cytochrome c into cytosol (Fig. 6c). In contrast, killed P. aeruginosa only induced a low level of cytochrome c release. Treatment with camptothecin also induced a significant release of cytochrome c. Similarly, camptothecin or live but not killed P. aeruginosa induced D4-GDI cleavage when cytosol fractions were probed for cleaved D4-GDI product by Western blotting (Fig. 6c).

P. aeruginosa down-regulates FLIPshort and FLIPlong in mast cells

FLIPs are endogenous proteins that regulate caspase-3 activation through interaction with caspase-8 (14, 31). To determine whether FLIPs are involved in live P. aeruginosa-induced mast cell apoptosis, HMC-1 cells were treated with live or killed P. aeruginosa strain 8821 for 24 h at the MOI of 1:50. Cell lysates were analyzed for both FLIPshort and FLIPlong by Western blotting. Treatment of mast cells with live P. aeruginosa induced decrease of both FLIPshort and FLIPlong, an effect similar to that of exotoxin A. Killed P. aeruginosa appears to have little effect on FLIP levels (Fig. 7). Treatment of HMC-1 cells with camptothecin induced reduction of FLIPs (Fig. 7). This result is in contrast to its lack of effect on Bcl-xS expression.

Surface Fas (CD95) is associated with FLIPs-regulated receptor-caspase-8 pathway and was reported to be up-regulated in epithelial cells by a laboratory strain of P. aeruginosa PAO-1 (32). We determined whether P. aeruginosa strain 8821 modulates surface Fas levels on mast cells. Treatment of HMC-1 cells with P. aeruginosa (mast cell to bacteria ratio of 1:50) for various times (3–48 h) did not affect the surface Fas levels as determined by flow cytometry (data not shown).


   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
Disclosures
 References
 
Mast cells play a critical role in the host defense against bacterial infection (1, 2, 3). To date, this important role of mast cells has been attributed to the release of mast cell mediators that in turn recruit other immune effector cells such as neutrophil to clear bacterial pathogen (1, 2, 3). Recently, we demonstrated an active mast cell-P. aeruginosa interaction, which leads to secretion of biologically active mast cell mediators such as IL-1{alpha} and IL-beta that induce human neutrophil transendothelial migration (4). However, little is known about the fate of mast cells after encountering bacterial pathogen. Because apoptosis has been shown to be one of the critical mechanisms in the host defense against P. aeruginosa infection, we investigated whether mast cells undergo apoptosis after encountering P. aeruginosa and the mechanisms involved in P. aeruginosa-induced mast cell apoptosis. We used a recently developed technique based on formamide-induced DNA denaturation combined with detection of denatured DNA with a mAb against ssDNA that allows specific detection of apoptotic cells (26). We provide compelling evidence that human mast cells undergo apoptosis after incubation with live P. aeruginosa.

P. aeruginosa-induced apoptosis was confirmed by the detection of caspase-3 activation. An active form of caspase-3 in P. aeruginosa-treated mast cells was detected by Western blotting and flow cytometry. P. aeruginosa-induced activation of caspase-3 was further verified by the cleavage of D4-GDI, an endogenous caspase-3 substrate. A central role for caspase-3 in the process of apoptosis has been well recognized. Depending on a specific cell type, two major pathways have been well described in the initiation of caspase-3 activation, the FLIPs-associated death receptor-caspase-8 pathway and the Bcl family-regulated mitochondrial pathway. Both pathways exist in mast cells (12, 18). Bcl family members consist of proapoptotic proteins (Bcl-xS, Bax, Bad, and others) and the antiapoptotic proteins (Bcl-xL, Bcl-2, and Bcl-w). The balance between proapoptotic and antiapoptotic members determines the fate of many types of cells. Bcl-xL and Bcl-xS are splice variants produced by alternative splicing of Bcl-x pre-mRNA. The antagonistic functions of Bcl-xL (antiapoptotic) and Bcl-xS (proapoptotic) have prompted several studies in an attempt to shift the alternative splicing in an effort to control the apoptotic process (21, 22). We found that a shift from Bcl-xL to Bcl-xS in human mast cells was induced by treatment with P. aeruginosa. To our knowledge, this demonstration represents the first that shows that alternative splicing of Bcl-xL and Bcl-xS is involved in bacterial pathogen-induced apoptosis in mammalian cells. One major advantage of using the mechanism of splicing shift producing variants with opposing effect is that one molecule of antiapoptotic Bcl-xL is replaced with one molecule of proapoptotic Bcl-xS, leading to an increased net effect in the control of apoptotic process.

The production of specific Bcl isoforms with opposite effects on the apoptotic response is likely controlled by the promoter usage (33). Several bcl-x gene promoters have been identified (33, 34). The usage of different promoters leads to the generation of different bcl gene products, with promoter 1 primarily producing Bcl-xL and promoter 2 producing Bcl-xL, Bcl-xS, and Bcl-x{gamma} (33). Accordingly, it is possible that upon P. aeruginosa infection human mast cells change the usage of bcl gene promoter leading to the decrease of Bcl-xL and increase of Bcl-xS. However, the promoter usage appears to be tissue specific (33). Thus, it remains to be determined whether P. aeruginosa-induced Bcl-x isoform shift also occurs in other cell types or other pathogen-induced apoptosis because different cell types possess distinct mechanisms in response to different bacterial pathogen. In addition, because mechanisms involved in live P. aeruginosa-induced mast cell apoptosis are likely multifactorial, the causative relationship between Bcl-xS/Bcl-xL levels and mast cell apoptosis requires further study.

It has been suggested that members of the Bcl-xL together with other Bcl-2 gene family members control mitochondrial membrane permeability during apoptosis by regulating the electrical and osmotic homeostasis of mitochondria (29, 35). Using DioC6 as a probe, we observed a loss of mitochondrial potential in mast cells treated with P. aeruginosa. In addition, P. aeruginosa treatment induced release of cytochrome c from mitochondria. These results support a role of mitochondrial pathway in P. aeruginosa-induced human mast cell apoptosis.

An additional mechanism in the initiation of caspase-3 activation is the FLIPs-associated death receptor-caspase-8 pathway. Cellular FLIPs structurally resemble caspase-8 except that they lack proteolytic activity (14). Thus, FLIPs function as intrinsic inhibitors of caspase-8 pathway activation. Treatment of mast cells with live P. aeruginosa reduced the protein levels of both FLIPlong and FLIPshort, suggesting a potential role of death receptor-caspase-8 pathway in P. aeruginosa-induced mast cell apoptosis. We also attempted to determine whether levels of cell surface Fas (CD95) on mast cells were altered by P. aeruginosa treatment because Fas was up-regulated by P. aeruginosa on epithelial cells (32). Little changes of surface Fas were observed when human mast cells were treated with P. aeruginosa for various times (3–48 h) (data not shown), suggesting that mast cells and epithelial cells likely respond differently to P. aeruginosa.

Interestingly, both ssDNA formation and activation of caspase-3 were induced by live, but not killed P. aeruginosa. Further studies are needed to determine the specific bacterial components that are responsible for inducing mast cell apoptosis. It is possible that live P. aeruginosa releases bacterial toxins that induce mast cell apoptosis. Our recent study showed that P. aeruginosa exotoxin A induces human mast cell apoptosis that is associated with reduced levels of FLIPs, a feature similar to that induced by live P. aeruginosa (10). However, we noticed that unlike live P. aeruginosa, exotoxin A did not induce increased expression of Bcl-xS. In addition, we have demonstrated that mitochondrial pathway is activated by live P. aeruginosa. This result is in contrast to exotoxin A, which induces mast cell apoptosis through a mitochondrial-independent pathway (10). Thus, exotoxin A may not be a major factor responsible for P. aeruginosa-induced mitochondrial pathway-mediated mast cell apoptosis. P. aeruginosa-derived azurin and cytochrome c have been implicated in macrophage and mast cell apoptosis (36). Alternatively, P. aeruginosa invasion into mast cells may initiate an intracellular event that directly targets the upstream of initiator caspases.

In summary, we reported for the first time that human mast cells undergo apoptosis after encountering live bacteria, P. aeruginosa, through a mechanism that is associated with a shift of alternative splicing from Bcl-xL to Bcl-xS. P. aeruginosa-induced caspase-3 activation in mast cell is accompanied by the loss of mitochondrial potential and reduced FLIPs levels, suggesting a potential role for the Bcl-mitochondrial pathway and FLIPs-caspase-8 pathway in P. aeruginosa-induced mast cell apoptosis.


   Disclosures
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
References
 
The authors have no financial conflict of interest.


   Footnotes
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by grants from the Canadian Institutes of Health Research, Canadian Cystic Fibrosis Foundation, Nova Scotia Health Research Foundation and Izaak Walton Killam Health Center. T.-J.L. is supported by a New Investigator Award from the Canadian Institutes of Health Research and an Investigatorship from Izaak Walton Killam Health Center. Back

2 Address correspondence and reprint requests to Dr. Tong-Jun Lin, Department of Pediatrics, Izaak Walton Killam Health Center, 5850 University Avenue, Halifax, Nova Scotia B3K 6R8, Canada. E-mail address: tong-jun.lin{at}dal.ca Back

3 Abbreviations used in this paper used: FLIP, Fas-associated death domain protein-like IL 1beta-converting enzyme-inhibitory protein; DioC6, 3,3'-dihexyloxacarbocyanine iodide; CBMC, cord blood-derived mast cell; HMC, human mast cell; BMMC, bone marrow-derived mast cell; MOI, multiplicity of infection. Back

Received for publication May 26, 2005. Accepted for publication September 4, 2006.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 

  1. Echtenacher, B., D. N. Mannel, L. Hultner. 1996. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381: 75-77. [Medline]
  2. Malaviya, R., T. Ikeda, E. Ross, S. N. Abraham. 1996. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-{alpha}. Nature 381: 77-80. [Medline]
  3. Prodeus, A. P., X. Zhou, M. Maurer, S. J. Galli, M. C. Carroll. 1997. Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature 390: 172-175. [Medline]
  4. Lin, T. J., R. Garduno, R. T. Boudreau, A. C. Issekutz. 2002. Pseudomonas aeruginosa activates human mast cells to induce neutrophil transendothelial migration via mast cell-derived IL-1{alpha} and beta. J. Immunol. 169: 4522-4530. [Abstract/Free Full Text]
  5. Hotchkiss, R. S., W. M. Dunne, P. E. Swanson, C. G. Davis, K. W. Tinsley, K. C. Chang, T. G. Buchman, I. E. Karl. 2001. Role of apoptosis in Pseudomonas aeruginosa pneumonia. Science 294: 1783
  6. Grassmé, H., S. Kirschnek, J. Riethmueller, A. Riehle, G. von Kürthy, F. Lang, M. Weller, E. Gulbins. 2000. CD95/CD95 ligand interactions on epithelial cells in host defense to Pseudomonas aeruginosa. Science 290: 527-530. [Abstract/Free Full Text]
  7. Hotchkiss, R. S., K. C. Chang, P. E. Swanson, K. W. Tinsley, J. J. Hui, P. Klender, S. Xanthoudakis, S. Roy, C. Black, E. Grimm, et al 2000. Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat. Immunol. 1: 496-501. [Medline]
  8. Rajan, S., G. Cacalano, R. Bryan, A. J. Ratner, C. U. Sontich, A. van Heerckeren, P. Davis, A. Prince. 2000. Pseudomonas aeruginosa induction of apoptosis in respiratory epithelial cells: analysis of the effects of cystic fibrosis transmembrane conductance regulator dysfunction and bacterial virulence factors. Am. J. Respir. Cell Mol. Biol. 23: 304-312. [Abstract/Free Full Text]
  9. Fox, B., T. B. Bull, A. Guz. 1981. Mast cells in the human alveolar wall: an electronmicroscopic study. J. Clin. Pathol. 34: 1333-1342. [Abstract/Free Full Text]
  10. Jenkins, C. E., A. Swiatoniowski, A. C. Issekutz, T. J. Lin. 2004. Pseudomonas aeruginosa exotoxin A induces human mast cell apoptosis by a caspase-8- and -3-dependent mechanism. J. Biol. Chem. 279: 37201-37207. [Abstract/Free Full Text]
  11. Calderón, G. M., J. Torres-López, T.-J. Lin, B. Chavez, M. Hernández, O. Muñoz, A. D. Befus, J. A. Enciso. 1998. Effects of toxin A from Clostridium difficile on mast cell activation and survival. Infect. Immun. 66: 2755-2761. [Abstract/Free Full Text]
  12. Yoshikawa, H., K. Tasaka. 2003. Caspase-dependent and -independent apoptosis of mast cells induced by withdrawal of IL-3 is prevented by Toll-like receptor 4-mediated lipopolysaccharide stimulation. Eur. J. Immunol. 33: 2149-2159. [Medline]
  13. Opferman, J. T., S. J. Korsmeyer. 2003. Apoptosis in the development and maintenance of the immune system. Nat. Immunol. 4: 410-415. [Medline]
  14. Tschopp, J., M. Irmler, M. Thome. 1998. Inhibition of fas death signals by FLIPs. Curr. Opin. Immunol. 10: 552-558. [Medline]
  15. Luo, X., I. Budihardjo, H. Zou, C. Slaughter, X. Wang. 1998. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94: 481-490. [Medline]
  16. Li, H., H. Zhu, C. J. Xu, J. Yuan. 1998. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491-501. [Medline]
  17. Green, D. R., G. Kroemer. 2004. The pathophysiology of mitochondrial cell death. Science 305: 626-629. [Abstract/Free Full Text]
  18. Yoshikawa, H., Y. Nakajima, K. Tasaka. 2000. Enhanced expression of Fas-associated death domain-like IL-1-converting enzyme (FLICE)-inhibitory protein induces resistance to Fas-mediated apoptosis in activated mast cells. J. Immunol. 165: 6262-6269. [Abstract/Free Full Text]
  19. Boise, L. H., M. González-Garcia, C. E. Postema, L. Ding, T. Lindsten, L. A. Turka, X. Mao, G. Nuñez, C. B. Thompson. 1993. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597-608. [Medline]
  20. Kelekar, A., C. B. Thompson. 1998. Bcl-2-family proteins: the role of the BH3 domain in apoptosis. Trends Cell. Biol. 8: 324-330. [Medline]
  21. Taylor, J. K., Q. Q. Zhang, J. R. Wyatt, N. M. Dean. 1999. Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides. Nat. Biotechnol. 17: 1097-1100. [Medline]
  22. Mercatante, D. R., C. D. Bortner, J. A. Cidlowski, R. Kole. 2001. Modification of alternative splicing of Bcl-x pre-mRNA in prostate and breast cancer cells: analysis of apoptosis and cell death. J. Biol. Chem. 276: 16411-16417. [Abstract/Free Full Text]
  23. Lin, T. J., T. B. Issekutz, J. S. Marshall. 2000. Human mast cells transmigrate through human umbilical vein endothelial monolayers and selectively produce IL-8 in response to stromal cell-derived factor-1{alpha}. J. Immunol. 165: 211-220. [Abstract/Free Full Text]
  24. Boudreau, R. T., R. Garduno, T. J. Lin. 2002. Protein phosphatase 2A and protein kinase C{alpha} are physically associated and are involved in Pseudomonas aeruginosa-induced interleukin 6 production by mast cells. J. Biol. Chem. 277: 5322-5329. [Abstract/Free Full Text]
  25. Kamath, S., V. Kapatral, A. M. Chakrabarty. 1998. Cellular function of elastase in Pseudomonas aeruginosa: role in the cleavage of nucleoside diphosphate kinase and in alginate synthesis. Mol. Microbiol. 30: 933-941. [Medline]
  26. Frankfurt, O. S., A. Krishan. 2001. Identification of apoptotic cells by formamide-induced DNA denaturation in condensed chromatin. J. Histochem. Cytochem. 49: 369-378. [Abstract/Free Full Text]
  27. Rottenberg, H., S. Wu. 1998. Quantitative assay by flow cytometry of the mitochondrial membrane potential in intact cells. Biochim. Biophys. Acta 1404: 393-404. [Medline]
  28. Na, S., T.-H. Chuang, A. Cunningham, T. G. Turi, J. H. Hanke, G. M. Bokoch, D. E. Danley. 1996. D4-GDI, a substrate of CPP32, is proteolyzed during Fas-induced apoptosis. J. Biol. Chem. 271: 11209-11213. [Abstract/Free Full Text]
  29. Vander Heiden, M. G., N. S. Chandel, E. K. Williamson, P. T. Schumacker, C. B. Thompson. 1997. Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell 91: 627-637. [Medline]
  30. Kiechle, F. L., X. Zhang. 2002. Apoptosis: biochemical aspects and clinical implications. Clin. Chim. Acta 326: 27-45. [Medline]
  31. Krueger, A., S. Baumann, P. H. Krammer, S. Kirchhoff. 2001. FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis. Mol. Cell. Biol. 21: 8247-8254. [Free Full Text]
  32. Jendrossek, V., H. Grassmé, I. Mueller, F. Lang, E. Gulbins. 2001. Pseudomonas aeruginosa-induced apoptosis involves mitochondria and stress-activated protein kinases. Infect. Immun. 69: 2675-2683. [Abstract/Free Full Text]
  33. Pecci, A., L. R. Viegas, J. L. Barañao, M. Beato. 2001. Promoter choice influences alternative splicing and determines the balance of isoforms expressed from the mouse bcl-X gene. J. Biol. Chem. 276: 21062-21069. [Abstract/Free Full Text]
  34. Tian, C., P. Gregoli, M. Bondurant. 2003. The function of the bcl-x promoter in erythroid progenitor cells. Blood 101: 2235-2242. [Abstract/Free Full Text]
  35. Shimizu, S., M. Narita, Y. Tsujimoto. 1999. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399: 483-487. [Medline]
  36. Zaborina, O., N. Dhiman, M. Ling Chen, J. Kostal, I. A. Holder, A. M. Chakrabarty. 2000. Secreted products of a nonmucoid Pseudomonas aeruginosa strain induce two modes of macrophage killing: external-ATP-dependent, P2Z-receptor-mediated necrosis and ATP-independent, caspase-mediated apoptosis. Microbiology 146: (Pt. 10):2521-2530. [Abstract/Free Full Text]




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jenkins, C. E.
Right arrow Articles by Lin, T.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jenkins, C. E.
Right arrow Articles by Lin, T.-J.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS